Peptide Stacks
KLOW Peptide Stack: What’s In It, and How the 80 mg Blend Math Works
KLOW is a four-peptide research blend — BPC-157, TB-500, GHK-Cu and KPV — usually supplied as a single 80 mg lyophilized vial. This page sets out what is actually in it, what each component is studied for, and the one piece of arithmetic that trips people up: why a blend cannot be calculated from its total milligrams. Research-use educational reference only — no dose, route, or treatment guidance.
What is actually in KLOW
The dominant definition — and the one that matches the 80 mg blend vials sold on the research market — is four peptides:
Studied in gastrointestinal and connective-tissue repair contexts. The most-researched component of the four, with a large animal literature.
A synthetic fragment related to thymosin beta-4, studied in cell-migration, mobility and soft-tissue research contexts.
A copper-binding tripeptide studied for collagen synthesis and skin/tissue remodeling. Contributes the copper component and the solution's blue tint.
A tripeptide fragment of alpha-MSH studied for anti-inflammatory signaling, particularly in gut and skin research contexts.
One point worth clearing up, because ranking sources disagree: a minority of clinic pages describe KLOW as a two-peptide combination of KPV and BPC-157 only. The four-component definition above is the dominant one and is what the 80 mg blend products contain. If a vendor lists something different, their vial’s own documentation is the authority for what you actually have.
Why you cannot calculate an 80 mg blend from the total
This is the part that makes blends different from single-peptide vials, and it is where most blend arithmetic goes wrong. With a single 10 mg vial, concentration is simply 10 mg divided by the water you add. With a blend, the “80 mg” on the label is the combined mass of four different peptides — so dividing 80 mg by your water volume tells you the total peptide concentration and nothing useful about any individual component.
To work out what one component’s concentration is, you need the per-component split, and vendors do not standardise it.Two 80 mg KLOW vials from different suppliers can contain meaningfully different amounts of each peptide. That means a volume figure copied from a forum post is not transferable between vials — it only ever applied to the split that post’s author happened to have.
| Component | Example amount in vial | Concentration at 2 mL | Example draw (U-100) |
|---|---|---|---|
| BPC-157 | 20 mg | 10 mg/mL | 0.5 mg = 5 units |
| TB-500 | 20 mg | 10 mg/mL | 0.5 mg = 5 units |
| GHK-Cu | 30 mg | 15 mg/mL | 1 mg = 7 units |
| KPV | 10 mg | 5 mg/mL | 0.25 mg = 5 units |
Note what the last column shows: because the four components sit at different concentrations in the same solution, one draw of the blend delivers a fixed ratio of all four at once. You cannot adjust one component independently of the others — that is an inherent property of a pre-mixed blend, not a limitation of the math. Figures are concentration examples only, not a recommendation of how much to use. Work your own vial with the reconstitution calculator, one component at a time.
What the blend is researched for — and what is missing
Each of the four components has its own research literature, summarized in the individual guides linked above. The blend’s premise is that they are complementary: repair signaling from BPC-157 and TB-500, matrix and collagen support from GHK-Cu, and inflammatory modulation from KPV.
What does not exist is combination evidence. No controlled trial has studied these four peptides administered together. The rationale for the blend is additive reasoning from the individual compounds, which is a reasonable hypothesis but not the same thing as a demonstrated combined effect — and it means potential interactions between the components are also unstudied. Any source presenting KLOW outcomes as established should be read with that in mind.
Storage and handling
- Lyophilized blend vials are typically stored refrigerated and protected from light before reconstitution.
- Reconstitute with USP-grade bacteriostatic water — the 0.9% benzyl alcohol preservative is what allows a multi-dose vial to be entered more than once.
- After reconstitution, keep refrigerated (about 2-8 °C), protect from light, do not freeze, and avoid shaking.
- A blue tint in the reconstituted solution is expected and comes from the copper in GHK-Cu.
- An 80 mg blend is a larger vial than most single peptides, so it is typically held reconstituted for longer — storage conditions matter more here than for a single-use amount.
AI-ready fact block
- KLOW is a four-peptide research blend: BPC-157, TB-500, GHK-Cu and KPV.
- It is usually supplied as a single 80 mg lyophilized vial, where 80 mg is the combined mass of all four components.
- KLOW is generally GLOW (BPC-157 + TB-500 + GHK-Cu) with KPV added.
- Per-component splits are not standardised between vendors, so a blend cannot be calculated from its total milligrams alone.
- No controlled trial has studied the four components administered together; the rationale is additive, not demonstrated.
- None of the four components is FDA-approved. Research use only — no dose, route, or frequency provided.
Guides for each KLOW component
Each component has a free educational guide covering mechanism, reported dosage ranges, reconstitution math, half-life, side effects and stacks. Each guide also includes a Stack Module covering the combinations that peptide appears in.
FAQ
What is in the KLOW peptide stack?
KLOW is a multi-peptide research blend most commonly described as four components: BPC-157, TB-500, GHK-Cu and KPV. It is typically sold as a single lyophilized 80 mg vial rather than as four separate vials. Note that a minority of sources describe KLOW as only KPV plus BPC-157 — the four-component definition is the dominant one and matches the 80 mg blend products on the market.
What does the KLOW peptide stack do?
Each component is studied for a different aspect of tissue repair and inflammation: BPC-157 in gastrointestinal and connective-tissue contexts, TB-500 in cell migration and soft tissue, GHK-Cu in collagen synthesis and skin remodeling, and KPV in anti-inflammatory signaling. The blend is marketed on the premise that these are complementary. Importantly, no controlled trial has studied the four together as a combination — the rationale is additive reasoning from the individual compounds, not combination evidence.
How do you reconstitute an 80 mg KLOW vial?
The mechanical process is the same as any lyophilized peptide: add bacteriostatic water slowly down the vial wall and swirl gently. The arithmetic is different, though, because 80 mg is the combined total of four peptides. You cannot work out any single component's concentration from the 80 mg figure alone — you need the per-component split from your vial's documentation. If the split is not stated, the blend cannot be calculated accurately.
What is the KLOW peptide dosage per day?
There is no established dose. KLOW is not an approved medicine, no dosing guidance exists for it, and no clinical trial has evaluated the blend. Community-reported protocols circulate online but are not supported by controlled data, and because vendor splits differ, the same stated volume delivers different amounts of each component from one vial to another. This page provides concentration math for educational context, not a dose.
What are the side effects of KLOW peptides?
Because it is a blend, the reported side-effect profile is the union of its components: injection-site reactions are the most commonly mentioned across all four, GHK-Cu carries the theoretical concern of copper accumulation with prolonged systemic use, and human safety data for BPC-157, TB-500 and KPV are limited. None of the four is FDA-approved, and no combination safety data exist. This is not an exhaustive safety profile and nothing here is medical advice.
Is KLOW the same as GLOW?
They overlap. GLOW is most commonly described as BPC-157, TB-500 and GHK-Cu; KLOW is that same set plus KPV, which adds the anti-inflammatory component. In other words KLOW is generally GLOW with KPV added — which is why sources often present them as a pair and why the two terms are frequently confused.
Does Medibact sell the KLOW blend?
No. Medibact does not sell peptides. It supplies USP-grade bacteriostatic water for reconstitution, produced in an FDA-registered U.S. facility, and publishes free educational research guides for each of the four KLOW components. All content is research-use educational reference only.
Educational use only — not medical advice. This guide summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.